Top 100 Hospital Chooses Global Med's Hospital Transfusion System Pomona Valley Hospital Medical Center Selects SafeTrace Tx(R) DENVER, June 16 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of an agreement for SafeTrace Tx(R)*, its advanced transfusion management system, with Pomona Valley Hospital Medical Center (PVHMC) in Pomona, California. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Crystal Lester, a Systems Analyst with PVHMC's Information Technology group, said, "The Laboratory and Information Management staff at Pomona Valley Hospital Medical Center selected SafeTrace Tx primarily because of Wyndgate's strong industry reputation and the system's ease of use and flexibility of application." Wm. Scott Dustin, Vice President of Sales and Marketing at Wyndgate Technologies, said, "We are pleased to have been selected to provide our products and services to enhance the transfusion service management system of a well-established and prestigious organization such as Pomona Valley Hospital Medical Center." Mr. Dustin added, "The delivery of accessible, quality healthcare is important to both PVHMC and Global Med Technologies." About Pomona Valley Hospital Medical Center Nationally recognized as a 100 Top Hospital, Pomona Valley Hospital Medical Center is a 436-bed acute care, not-for-profit, teaching hospital. Its staff of more than 600 physicians, 2,400 employees and 800 volunteers offers comprehensive medical services through three Centers of Excellence serving Eastern Los Angeles and Western San Bernardino counties. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000; or Investor Relations, John Nesbett or Jordan Silverstein, both of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies, Inc. Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/

Copyright